Why did you participate in the Biomapas Academy?
Everything started when I had a trip to a career fair during my studies. This was the first time I met Biomapas in person as there were several lecturers that presented the company itself and its activities. I remember thinking that I would like to work with this team as it piqued my interest.
Later, when I was working on my master’s degree, I came across an advertisement on social media for the Biomapas Academy. I already knew that I wanted to learn more about the pharma industry and was interested in various opportunities, so I applied for this opportunity.
How was your experience during the three months?
The Academy was a continuous cycle spanning several months of interesting lectures from true professionals with extensive knowledge. During this short time, I learned a lot about product development, research, safety information and its systems, different possible roles and their responsibilities, and new opportunities where young specialists can grow and find their place in the life sciences industry.
What did the future hold for you after the Academy?
A while after the Academy, I officially became part of Biomapas and its big family! With my background being an MPharm, I was always interested in drug safety. Therefore, I am working in the Pharmacovigilance Department as a Pharmacovigilance Project Management Assistant. I must say there are many interesting things to learn and experience that I am looking forward to with my team.
What would you say to the future participants?
If you are thinking about participating in the Academy, do not hesitate. Being an alumnus, I can say that you will definitely see the pharma industry from within. It will broaden your understanding; you will gain needed knowledge and experience in life sciences and will be able to apply that information working in your chosen field. I hope to see you at Biomapas!
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
The Perfect Partnership: How Mid-Sized CROs and Site Networks Deliver Clinical Trial Success
In this webinar, learn how the right size of CRO and the right type of site network partnership can deliver clinical trial success.
Breaking the Silos Across Medical Information & Pharmacovigilance – Leveraging Technology for Operational Efficiency
This whitepaper shows how a PV/MI Single Source of Truth boosts data management, compliance, and efficiency for complex therapies.
Harmonizing Product Information Across Baltic Markets
Navigating multilingual product information across several markets can be complex – but it doesn’t have to be. In this case study, we share how one of our partner companies successfully harmonized their SmPC, PIL, and labelling across the Baltic region, working with...
Dossier Transformation for Market Expansion
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...
Whitepaper: Computerised System Validation & Pharmacovigilance
This whitepaper explores how optimised computer system validation (CSV) strategies strengthen risk management, ensure data integrity in pharmacovigilance systems, and support compliance through a real-world cloud-based safety database case study.
Unlock Trial Success with the FSP Hybrid Model
Learn how the FSP hybrid model combines the best of FSO and FSP in clinical trials, enhancing operational control and flexibility.
Breaking silos across Medical Information & Pharmacovigilance
Discover solutions for effective PV & MI data management, including handling Adverse Events, Product Quality Complaints, and MI inquiries. Our experts will walk you through real-life examples and hands-on solutions.
Unlocking Success. The FSP Advantage in Clinical Research
FSP is a rising trend in clinical research, expected to gain further prominence due to its cost-effectiveness and demand for specialised expertise. Our FSP model offers benefits such as cost savings, expert advice, flexibility, and risk mitigation. Let’s discuss how...
Affiliate Based Outsourcing Model for Regulatory Affairs.
Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different...
Regulatory Outsourcing in the CEE Region
In this informative session we decode the intricate landscape of regulatory affairs outsourcing in the CEE region and provide practical, implementable strategies to optimize and maximize your operations and outsourcing strategies.Let’s discuss how we can streamline...
